Remove DNA Remove Life Science Remove Reagent Remove Scientist
article thumbnail

The latest drug discovery product launches

Drug Discovery World

Several new products for the life sciences sector have been launched over the last month, from miniature semiconductor chip (MSC) technology to a new inhalation testing service. The platform works with the SYNTAX Hi-Fidelity reagent kits for synthesising longer oligos. DDW provides an update.

article thumbnail

Up to 8 recipients to be awarded grants for genomic research

Drug Discovery World

Beckman Coulter Life Sciences has released a call for registrations for its SPRI Grants for Genomic Research, which the company describes as part of its commitment to the next generation of researchers and scientists. . Applications will be accepted until 15 December 2022. .

Genome 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Busting common myths about lab automation 

Drug Discovery World

Ernesto Staroswiecki, Senior Manager, R&D, at Beckman Coulter Life Sciences takes readers through common lab automation myths. Valuable scientists may also become bored and look for more exciting work elsewhere that makes better use of their education and skills. We cannot forget about managing and analysing data.

Reagent 111
article thumbnail

Busting common myths about lab automation 

Drug Discovery World

Ernesto Staroswiecki, Senior Manager, R&D, at Beckman Coulter Life Sciences takes readers through common lab automation myths. Many automation solutions can perform several different tasks and can be paired with other equipment to automate a range of tasks, such as DNA extraction and sequencing, PCR, and Western blots.

Reagent 98
article thumbnail

Transitioning Between Academia and Industry: Advice from Leading Scientists That Made the Switch

XTalks

Leaving academia for industry is a route that academic scientists and professors did not traditionally pursue in the past due to perceived differences in skillsets, experiences and even associated stigmas. WeiQi Lin, MD, PhD, executive vice president of research & development and principal scientist, DURECT Corporation.

article thumbnail

Modernizing cell culture processes for the next wave of genomic medicine

Pharmaceutical Technology

With scientists fervently developing mRNA vaccines, nucleic acid therapeutics, and viral vector-based gene therapies, clinicians are set to have a growing number of tools available to treat a wide range of conditions, from infectious diseases to genetic disorders and more. The field of genomic medicine has reached a true turning point.

Genome 244
article thumbnail

CRISPR breakthroughs: New solutions for common diseases

Drug Discovery World

Rolf Turk , Senior Manager, Genomics Medicine at Integrated DNA Technologies, examines how CRISPR is being used to enhance cancer therapies. Nucleic acid-based diagnostics, which typically require PCR reagents and laboratory equipment, are crucial for identifying, treating, and preventing common infectious diseases.

DNA 98